Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Porter

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
Cancer Treatment and Research|September 26, 2009
Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantationDavid L Porter, Elizabeth O Hexner, Sarah Cooley, et al.
American Journal of Hematology|August 29, 2007
Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin levelDonald E Tsai, Anthony Mato, David L Porter, et al.
Journal of Cancer|July 1, 2011
Chimeric Antigen Receptor Therapy for B-cell MalignanciesDavid L Porter, Michael Kalos, Zhaohui Zheng, et al.
Transplantation and Cellular Therapy|July 3, 2023
Reflections: A New Monthly Feature in Transplantation and Cellular TherapyKeith M Sullivan, Stephen J Forman, Robert Korngold, et al.
American Journal of Hematology|February 17, 2015
Voriconazole-induced periostitis after allogeneic stem cell transplantationJohn H Baird, Belinda K Birnbaum, David L Porter, et al.
Blood|May 23, 2015
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaShannon L Maude, David T Teachey, David L Porter, et al.
Bone Marrow Transplantation|May 26, 2018
Prevention and treatment of relapse after stem cell transplantation in lymphoid malignanciesAnna Sureda, Peter Dreger, Michael R Bishop, et al.
Journal of the American Academy of Dermatology|January 29, 2008
Cutaneous Hodgkin's diseaseCamille E Introcaso, Jonathan Kantor, David L Porter, et al.
Blood|March 1, 2014
Antibody-modified T cells: CARs take the front seat for hematologic malignanciesMarcela V Maus, Stephan A Grupp, David L Porter, et al.
The New England Journal of Medicine|August 12, 2011
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemiaDavid L Porter, Bruce L Levine, Michael Kalos, et al.
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
Cancer Treatment and Research|September 26, 2009
Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantationDavid L Porter, Elizabeth O Hexner, Sarah Cooley, et al.
American Journal of Hematology|August 29, 2007
Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin levelDonald E Tsai, Anthony Mato, David L Porter, et al.
Journal of Cancer|July 1, 2011
Chimeric Antigen Receptor Therapy for B-cell MalignanciesDavid L Porter, Michael Kalos, Zhaohui Zheng, et al.
Transplantation and Cellular Therapy|July 3, 2023
Reflections: A New Monthly Feature in Transplantation and Cellular TherapyKeith M Sullivan, Stephen J Forman, Robert Korngold, et al.
American Journal of Hematology|February 17, 2015
Voriconazole-induced periostitis after allogeneic stem cell transplantationJohn H Baird, Belinda K Birnbaum, David L Porter, et al.
Blood|May 23, 2015
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaShannon L Maude, David T Teachey, David L Porter, et al.
Bone Marrow Transplantation|May 26, 2018
Prevention and treatment of relapse after stem cell transplantation in lymphoid malignanciesAnna Sureda, Peter Dreger, Michael R Bishop, et al.
Journal of the American Academy of Dermatology|January 29, 2008
Cutaneous Hodgkin's diseaseCamille E Introcaso, Jonathan Kantor, David L Porter, et al.
Blood|March 1, 2014
Antibody-modified T cells: CARs take the front seat for hematologic malignanciesMarcela V Maus, Stephan A Grupp, David L Porter, et al.
The New England Journal of Medicine|August 12, 2011
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemiaDavid L Porter, Bruce L Levine, Michael Kalos, et al.
Pageof 20